05:01:41 EST Mon 25 Jan 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Shell Summary for Jan. 11, 2021

2021-01-11 20:29 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 11.38 points to 885.33 Monday. Geoff Balderson's Dynamo Capital Corp. (DDD: suspended) plans to acquire a U.S. teleheath company, CareSpan Holdings Inc., for the shell's qualifying transaction. The shell will roll back 1 for 4.67, leaving it with 963,597 shares issued, then issue 27,142,873 shares to its target's shareholders.

CareSpan was founded in 2010. It now has "over 50" doctors using its telehealth platform, Clinic-in-the-Cloud. In the nine months to Sept. 30, 2020, the company had revenue of $1.58-million (U.S.). We should find out whether it is profitable when the shell submits a QT filing statement. Before the QT can close, CareSpan must raise $4-million to $6.5-million at 70 cents. The resulting issuer will use the proceeds for acquisitions and product development.

CareSpan's founder and chief medical officer is Dr. Terry Knapp of Colorado. He practised as a plastic surgeon in California for 17 years. In 1992, he co-founded and was the chief executive officer of LipoMatrix Inc., a maker of breast implants. LipoMatrix was acquired in 1998 by a California company, Sierra Medical Technologies Inc., for an undisclosed amount. In 1999, the European approval (CE mark) for LipoMatrix's implant product was suspended, and Sierra stopped selling it in all jurisdictions. Patients reported complications such as swelling, and hundreds of lawsuits arose in Europe and the United States. The company won some cases and settled others, paying out millions.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2021 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.